There are 717 resources available
47MO - Efficacy and quality of life (QOL) in premenopausal Asian patients (pts) with hormone receptor–positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC) treated in the MONALEESA (ML)-7 study
Presenter: Yen-Shen Lu
Session: Mini oral session on Breast cancer
Resources:
Abstract
Slides
Webcast
48MO - Ribociclib (RIB) + letrozole (LET) in Asian patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor-2–negative (HER2−) advanced breast cancer (ABC): Subgroup analysis of the phase IIIb CompLEEment-1 trial
Presenter: Sanjoy Chatterjee
Session: Mini oral session on Breast cancer
Resources:
Abstract
Slides
Webcast
3MO - IMpassion031: Results from a phase III study of neoadjuvant (neoadj) atezolizumab + chemo in early triple-negative breast cancer (TNBC)
Presenter: Shigehira Saji
Session: Mini oral session on Breast cancer
Resources:
Abstract
Slides
Webcast
49MO - IMpassion130: Final OS analysis from the pivotal phase III study of atezolizumab + nab-paclitaxel vs placebo + nab-paclitaxel in previously untreated locally advanced or metastatic triple-negative breast cancer
Presenter: Hiroji Iwata
Session: Mini oral session on Breast cancer
Resources:
Abstract
Slides
Webcast
5MO - Evaluation of pathological complete response (pCR) after neoadjuvant chemo-radiation therapy for primary breast cancer (JCOG0306A1)
Presenter: Tadahiko Shien
Session: Mini oral session on Breast cancer
Resources:
Abstract
Slides
Webcast
4MO - Machine learning intratumoral and peritumoral magnetic resonance imaging radiomics for predicting disease-free survival in patients with early-stage breast cancer (RBC-01 Study)
Presenter: Wei Ren
Session: Mini oral session on Breast cancer
Resources:
Abstract
Slides
Webcast
299MO - Efficacy and safety of entrectinib in an Asian population with <italic>NTRK</italic> fusion-positive (fp) solid tumours or <italic>ROS1</italic>-fp NSCLC
Presenter: Daniel Shao Weng Tan
Session: Mini oral session on Developmental and precision medicine
Resources:
Abstract
Slides
Webcast
300MO - Impact of dihydropyrimidine dehydrogenase (DPD) genotype on fluoropyrimidine-related toxicity in Asian population
Presenter: Masashi Kanai
Session: Mini oral session on Developmental and precision medicine
Resources:
Abstract
Slides
Webcast
301MO - Genomic HLA as a predictive biomarker for survival among non-small cell lung cancer patient treated with single agent immunotherapy
Presenter: Afaf Abed
Session: Mini oral session on Developmental and precision medicine
Resources:
Abstract
Slides
Webcast
378MO - EMPOWER-Lung 1: Phase III first-line (1L) cemiplimab monotherapy vs platinum-doublet chemotherapy (chemo) in advanced non-small cell lung cancer (NSCLC) with programmed cell death-ligand 1 (PD-L1) ≥50%
Presenter: Ahmet Sezer
Session: Mini oral session on Thoracic cancers
Resources:
Abstract
Slides
Webcast